Skip to content
  • Sunday, June 1, 2025

New Economy World

The world economy is the economy of all humans in the world

Banner Add
  • Home
  • Blog
  • Finance News
  • Insurance
  • Investing
  • Construction
  • Property
  • Stock
  • Tech
  • Venture Capital
  • Home
  • Blog
  • claimed

Tag: claimed

Tech

Solid, which claimed to be the ‘AWS of fintech,’ files for bankruptcy after raising nearly $81M in funding

09/04/2025
admin

Banking-as-a-service startup Solid (formerly called Wise) has filed for Chapter 11 bankruptcy protection, according to documents…

Stock

Tesla's Musk suggests DeepSeek 'obviously' has more NVIDIA GPUs than claimed

27/01/2025
admin

Tesla's Musk suggests DeepSeek 'obviously' has more NVIDIA GPUs than claimed#Tesla039s #Musk #suggests #DeepSeek #039obviously039 #NVIDIA…

Finance and Economics

Recent Posts

Finance News

Smart City Cybersecurity: Key Risks Explained

01/06/2025
admin
Stock

Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

01/06/2025
admin
Tech

TC Sessions: AI Trivia Countdown — score big on tickets

01/06/2025
admin
Finance News

Adecoagro Trades Cheap, But Lacks Near-Term Catalysts

01/06/2025
admin
Stock

Trump, Xi likely to speak soon, Treasury's Bessent says

01/06/2025
admin
Finance News

Verizon: Another Bad Plan

01/06/2025
admin
Stock

Exclusive-Ukraine to set out roadmap for peace at Istanbul talks, document shows

01/06/2025
admin

Recent Posts

Finance News

Smart City Cybersecurity: Key Risks Explained

01/06/2025
admin
Stock

Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

01/06/2025
admin

Recent Posts

Finance News

Smart City Cybersecurity: Key Risks Explained

01/06/2025
admin
Stock

Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

01/06/2025
admin

Recent Posts

Finance News

Smart City Cybersecurity: Key Risks Explained

01/06/2025
admin
Stock

Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

01/06/2025
admin
New Economy World News